You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-07-06 1 Label (April 2017), # 2 Exhibit B: U.S. Patent No. 9,393,237, # 3 Exhibit C: Actavis ANDA Approved Labeling…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2017-07-08 10 U.S. Patent No. 9,393,237, # 4 Exhibit 3: U.S. Patent No. 8,658,663, # 5 Exhibit 4: U.S. Patent No. 8,946,251…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2017-07-10 11 HOLDER or l'ATENT OR TRADEMARK. I us 9,393,237 7/19/2016 … ~ 0 Trademarks or ~Patents. ( O the patent action involves 35 U.S.C. § 292.): DOCKET… AO120 Patent Form filed. (jr) (Entered: 07/10/2017) 10 July 2017 PACER Document … REPORT ON THE Director of the U.S. Patent and Trademark Office … ACTION REGARDING A PATENT OR Alexandria, VA 22313 External link to document
2017-07-20 22 paroxetine derivatives are is disclosed in US 6,063,927. US 6,440,459 and US 2004/0143120 disclose paroxetine…ANDERSEN ET AL. !S.K./ A15 US-6,063 927 5/16/2000 …issue date of the patent, and will include the patent term adjustment on the patent. Any request for reconsideration…infringes Plaintiff’s U.S. Patent Nos. 5,874,447 (“’447 patent”); 7,598,271 (“’271 patent”); 8,658,663…,663 (“’663 patent”); and 8,946,251 (“’251 patent”) (collectively “patents-in-suit”) under 35 External link to document
2017-07-25 26 U.S. Patent No. 5,955,475, # 3 Exhibit 35: U.S. Patent No. 6,113,944, # 4 Exhibit 36: U.S. Patent No. …6,645,523, # 5 Exhibit 37: U.S. Patent No. 6,660,298, # 6 Exhibit 38: U.S. Patent No. 6,699,882, # 7 Exhibit…40: U.S. Patent Application Publication No. 2004/0067254 (Lemmens), # 9 Exhibit 41: U.S. Patent No. 6,369,051…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2017-10-02 50 A: Brisdelle Label, # 2 Exhibit B: U.S. Patent No. 9,393,237, # 3 Exhibit C: Prinston ANDA Approval Letter…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.